Holen Sie sich die Stockscreener-App
3.87
2.03%
-0.08
Handel nachbörslich:
3.70
-0.17
-4.39%
Schlusskurs vom Vortag:
$3.95
Offen:
$3.99
24-Stunden-Volumen:
692.82K
Relative Volume:
1.87
Marktkapitalisierung:
$47.20M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+53.57%
1M Leistung:
+100.52%
6M Leistung:
+101.56%
1J Leistung:
-91.64%
1-Tages-Spanne:
$3.45
$3.99
1-Wochen-Bereich:
$2.70
$3.99
52-Wochen-Spanne:
$1.345
$53.17
Q 32 Bio Inc Stock (QTTB) Company Profile
Firmenname
Q 32 Bio Inc
Sektor
Branche
Telefon
781-999-0232
Adresse
830 WINTER STREET, WALTHAM
Vergleichen Sie QTTB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
3.87 | 48.18M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-11 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2025-02-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-12-11 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-12-11 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-12-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-10-24 | Eingeleitet | Raymond James | Strong Buy |
| 2024-09-11 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-17 | Eingeleitet | Guggenheim | Buy |
| 2024-05-21 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-11 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-02 | Eingeleitet | Piper Sandler | Overweight |
| 2023-07-28 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-02-22 | Bestätigt | BTIG Research | Neutral |
| 2022-02-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-02-22 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-03-02 | Eingeleitet | Stifel | Hold |
| 2020-12-14 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-08-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-25 | Fortgesetzt | BofA/Merrill | Buy |
| 2020-05-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-03-16 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-02-24 | Eingeleitet | Chardan Capital Markets | Buy |
| 2019-11-01 | Eingeleitet | Oppenheimer | Perform |
| 2019-09-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-04-12 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Q 32 Bio Inc Aktie (QTTB) Neueste Nachrichten
Can Q32 Bio Inc. rally from current levelsQuarterly Trade Report & Precise Swing Trade Alerts - newser.com
Is Q32 Bio Inc. meeting your algorithmic filter criteriaJuly 2025 Pullbacks & Free Safe Capital Growth Stock Tips - newser.com
How institutional ownership impacts Q32 Bio Inc. stockWeekly Investment Summary & Stock Market Timing Techniques - newser.com
Applying sector rotation models to Q32 Bio Inc.July 2025 Summary & Verified Momentum Watchlists - newser.com
Detecting price anomalies in Q32 Bio Inc. with AI2025 Momentum Check & Weekly Return Optimization Alerts - newser.com
Published on: 2025-10-12 02:48:56 - newser.com
Will Q32 Bio Inc. stock split again soon2025 Valuation Update & Reliable Volume Spike Trade Alerts - newser.com
Volatility clustering patterns for Q32 Bio Inc.Portfolio Return Report & AI Powered Trade Plan Recommendations - newser.com
Fierce Biotech Layoff Tracker 2025: Ascidian Tx trims team; Ferring plots 500 layoffs - fiercebiotech.com
Published on: 2025-10-09 06:42:45 - newser.com
Is Q32 Bio Inc. stock poised for growthPortfolio Return Report & Low Drawdown Trading Strategies - newser.com
Key metrics from Q32 Bio Inc.’s quarterly dataLong Setup & Low Risk High Win Rate Picks - newser.com
Leading vs lagging indicators on Q32 Bio Inc. performanceAnalyst Downgrade & Entry and Exit Point Strategies - newser.com
Identifying reversal signals in Q32 Bio Inc.2025 Big Picture & Precise Entry and Exit Recommendations - newser.com
Morning Market Movers: XBIO, UPC, GLTO Spark Big Moves - RTTNews
Biotech Stocks Surge After Hours: PCSA, PALI, And QTTB Lead On Volume And Speculation - Nasdaq
What analysts say about Q32 Bio Inc stockInsider Buying Signals & Outstanding Growth Strategies - earlytimes.in
Q32 Bio Trades At Lows While Betting On Immune Breakthroughs - Finimize
Lupus Nephritis Market to Advance at a CAGR of 8.5% During the Forecast Period (2025-2034) | DelveInsight - The AI Journal
Is now a turning point for Q32 Bio Inc.Quarterly Portfolio Summary & Community Consensus Trade Alerts - newser.com
Q32 Bio Inc. (NASDAQ:QTTB) Receives Consensus Recommendation of “Hold” from Analysts - Defense World
Will Q32 Bio Inc. stock recover after recent dropJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
Applying Elliott Wave Theory to Q32 Bio Inc.Weekly Stock Report & Technical Confirmation Trade Alerts - newser.com
Why Q32 Bio Inc. is moving todayTrade Analysis Report & Expert Approved Momentum Ideas - newser.com
Q32 Bio Inc.’s Promising Alopecia Areata Treatment Trial Update - MSN
What to do if you’re stuck in Q32 Bio Inc.CPI Data & Safe Capital Growth Tips - newser.com
What MACD and RSI say about Q32 Bio Inc.2025 Breakouts & Breakdowns & Risk Managed Investment Strategies - newser.com
Layoff Tracker: CSL Vifor, Bolt Cut Staff - BioSpace
Relative strength of Q32 Bio Inc. in sector analysisEarnings Beat & High Conviction Buy Zone Picks - newser.com
How to forecast Q32 Bio Inc. trends using time seriesJuly 2025 Earnings & Reliable Momentum Entry Alerts - newser.com
Goldman Sachs Group Inc. Boosts Stake in Q32 Bio Inc. $QTTB - Defense World
A house dividing: Anaptysbio wants separate pipeline, royalty firms - BioWorld MedTech
Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday - MSN
What drives Q32 Bio Inc stock priceCapital Gains Strategies & Low Entry Risk Stocks - earlytimes.in
Finanzdaten der Q 32 Bio Inc-Aktie (QTTB)
Es liegen keine Finanzdaten für Q 32 Bio Inc (QTTB) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Q 32 Bio Inc-Aktie (QTTB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Violette Shelia M. | Chief Scientific Officer |
Aug 26 '25 |
Sale |
1.80 |
2,990 |
5,385 |
58,384 |
| Kalowski Lee | CFO and President |
Aug 26 '25 |
Sale |
1.80 |
4,240 |
7,636 |
49,010 |
| Violette Shelia M. | Chief Scientific Officer |
Oct 15 '24 |
Option Exercise |
7.29 |
6,000 |
43,740 |
23,874 |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):